Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).
about
Recent developments in the management of invasive fungal infections in patients with oncohematological diseasesDiagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Invasive fungal infections in transplant recipientsProspective observational multicenter study to define a diagnostic algorithm for biliary candidiasis.Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.Bone suppression increases the visibility of invasive pulmonary aspergillosis in chest radiographsDiagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosisIncidence of Cyp51 A key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995-2013Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.Extrasinonasal infiltrative process associated with a sinonasal fungus ball: does it mean invasive fungal sinusitis?Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilitiesSuccess rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in KoreaAntimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections.Our 2015 approach to invasive pulmonary aspergillosis.Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation.Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools.Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Invasive aspergillosis successfully treated by combined antifungal therapy and immunosuppressive monotherapy two months following heart transplantation.Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients.Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia.Current Algorithms in Fungal Diagnosis in the Immunocompromised Host.Case report: false positive elevated serum-galactomannan levels after autologous hematopoietic stem cell transplantation caused by oral nutritional supplements.Analysis of the efficiency and costs of antifungal prophylaxis and mycological diagnostics in patients undergoing allogeneic haematopoietic cell transplantation: "real life" evaluation.(1→3)-β-d-Glucan and Galactomannan for Differentiating Chemical "Black Particles" and Fungal Particles Inside Peritoneal Dialysis Tubing.Oral administration of live- or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1→3)-β-D-glucan(1→3)-β-D-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study.Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients.Prospective evaluation of the SeptiFAST multiplex real-time PCR assay for surveillance and diagnosis of infections in haematological patients after allogeneic stem cell transplantation compared to routine microbiological assays and an in-house real-Galactomannan testing during mold-active prophylaxis.Fungus-specific CD4(+) T cells for rapid identification of invasive pulmonary mold infection.The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxFungal infections in immunocompromised patients.Standardization and characterization of antigens for the diagnosis of aspergillosis.Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review.
P2860
Q28077381-115356AD-AD89-41DF-B423-6372DE66DBA6Q30608976-F3EECEE8-35CB-4F9B-B93D-4561F911FE64Q33695215-8D0BA199-7C0E-43A1-AB8A-8225EB544AAAQ34168602-1A79861D-9C13-4E8C-B8D2-E49B9314D939Q34281346-478283B1-819C-4123-84C8-FD71B3EFAC09Q34287044-A26A4ACD-0E8A-4776-A55D-585C3BD6796CQ34602520-91DE21D8-2FE4-4828-9F5A-ACD1F8CA8646Q35215022-C31E5551-04C5-4F2C-97D4-74DA154AB45CQ35715408-D51842E9-1A3B-4C1B-AC0A-5B84F1F8CCA6Q37114847-55582455-6342-412B-8EBD-0883E37838A1Q37336198-6CD1837D-1144-4F34-A75F-E056FE8B8D0CQ37473671-693D9086-96F4-4C9F-9E99-FBE88B68B77EQ38013661-F1757967-BC4D-44BE-8B64-ABD7332DA359Q38067507-6B3ABC59-AFC6-46D1-8EF2-82961A6CF4B0Q38391049-7A8C7709-8C81-49D0-BDDE-DCA2EC6DFAC6Q38667725-BD38CC21-7D93-4810-AB18-8A28166CFB01Q38686517-087B013D-4287-4A22-AD20-01519E0952DDQ38817878-379A8F3B-0EC4-4259-AD19-A12673833D2FQ38912624-F7F4E073-8987-43CE-98C8-39E2F2D97862Q38965488-FE8AA735-E213-4E51-B69A-1C977C24057DQ40041299-900B1A6B-D25C-448D-9AED-158AD78EB0A3Q40092968-6B8E0577-97EF-406C-ADEA-08C6C53DB547Q40252332-7B5DF567-6644-418D-BB74-2880D5F80441Q40263137-503533CF-934B-406E-B698-B4A2F31D6C8CQ40287041-27DA1220-52F0-43EE-84EF-6E406CBC9D45Q40424803-4DCADF7D-4DE0-4019-8347-5B83C9790E1AQ40454880-C6074BD3-90C1-4E4D-9D46-16DDF1062609Q40671481-77843C25-DC61-4FF7-BD63-F018628A140EQ40886644-BB4F8B19-FE37-485B-B029-CB48FD4EF481Q40926532-38D37299-B150-49B5-9AE1-8042671B4315Q41152901-E3DD6542-F8A0-4843-8B34-9052EF2FB3B5Q41349103-B3B6B76F-3698-47C9-B0EB-09A54F743898Q41822618-E71A1596-2AB2-423F-9BA1-FF1DB9EF53B7Q41929754-4CE32407-1EED-4CC3-B8D8-7B9D51DD95BEQ42738330-C0EDA1FE-2315-4E42-A2D9-6056743FF418Q43562189-55A11876-4EAB-43B5-826F-443FAE7619F5Q43600554-2B462586-985D-404B-927B-044C91C5602EQ44620717-E330AFD8-F788-4E79-A5C3-388A7FDDC6BBQ46258392-D9D799F5-07EC-4E2C-A046-D004750CEBFDQ47117346-9FFB6343-B868-4E9C-A43C-04D0FAE85755
P2860
Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diagnosis of invasive fungal i ...... matology and Oncology (AGIHO).
@en
Diagnosis of invasive fungal i ...... y for Haematology and Oncology
@nl
type
label
Diagnosis of invasive fungal i ...... matology and Oncology (AGIHO).
@en
Diagnosis of invasive fungal i ...... y for Haematology and Oncology
@nl
prefLabel
Diagnosis of invasive fungal i ...... matology and Oncology (AGIHO).
@en
Diagnosis of invasive fungal i ...... y for Haematology and Oncology
@nl
P2093
P2860
P356
P1433
P1476
Diagnosis of invasive fungal i ...... ematology and Oncology (AGIHO)
@en
P2093
C P Heussel
G Maschmeyer
Infectious Diseases Working Pa ...... y for Haematology and Oncology
K Donhuijsen
P2860
P304
P356
10.1093/ANNONC/MDR407
P577
2011-09-23T00:00:00Z